CAFORIO, ALIDA LINDA PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.836
AS - Asia 10.517
EU - Europa 6.326
AF - Africa 3.025
SA - Sud America 2.971
OC - Oceania 302
Continente sconosciuto - Info sul continente non disponibili 135
Totale 42.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.297
SG - Singapore 3.871
BR - Brasile 1.877
CN - Cina 1.446
HK - Hong Kong 1.428
VN - Vietnam 827
IT - Italia 817
FI - Finlandia 608
PL - Polonia 596
DE - Germania 424
RU - Federazione Russa 323
SE - Svezia 306
FR - Francia 293
UA - Ucraina 257
GB - Regno Unito 225
AR - Argentina 219
NL - Olanda 162
IN - India 156
ID - Indonesia 154
TR - Turchia 152
EC - Ecuador 148
IE - Irlanda 134
IQ - Iraq 125
GR - Grecia 124
MX - Messico 121
AT - Austria 118
CO - Colombia 118
CI - Costa d'Avorio 116
JP - Giappone 116
PE - Perù 114
ES - Italia 110
ZA - Sudafrica 110
VE - Venezuela 106
BJ - Benin 100
KR - Corea 99
HN - Honduras 98
CZ - Repubblica Ceca 95
PK - Pakistan 95
RS - Serbia 94
TN - Tunisia 94
BY - Bielorussia 93
AO - Angola 91
SA - Arabia Saudita 91
UZ - Uzbekistan 91
AZ - Azerbaigian 90
MA - Marocco 89
PA - Panama 89
CH - Svizzera 88
SN - Senegal 88
CL - Cile 87
DZ - Algeria 87
IR - Iran 87
MZ - Mozambico 87
UG - Uganda 87
JO - Giordania 86
AE - Emirati Arabi Uniti 85
KE - Kenya 85
KG - Kirghizistan 85
PY - Paraguay 85
UY - Uruguay 84
BE - Belgio 83
DO - Repubblica Dominicana 83
HR - Croazia 83
IS - Islanda 83
TT - Trinidad e Tobago 83
HU - Ungheria 82
JM - Giamaica 82
PH - Filippine 82
LC - Santa Lucia 81
LU - Lussemburgo 81
AL - Albania 80
SK - Slovacchia (Repubblica Slovacca) 79
YE - Yemen 79
GN - Guinea 78
IL - Israele 78
LV - Lettonia 78
NO - Norvegia 78
CA - Canada 77
ET - Etiopia 77
NP - Nepal 77
NI - Nicaragua 76
GM - Gambi 75
MY - Malesia 75
TW - Taiwan 75
TZ - Tanzania 75
BW - Botswana 74
CR - Costa Rica 74
EG - Egitto 74
GF - Guiana Francese 74
GT - Guatemala 74
LB - Libano 74
NZ - Nuova Zelanda 74
GE - Georgia 73
KZ - Kazakistan 73
SO - Somalia 73
GA - Gabon 72
GH - Ghana 72
MD - Moldavia 72
PS - Palestinian Territory 72
AM - Armenia 71
Totale 38.504
Salva come PNG Salva come JPEG
Città #
Fairfield 2.731
Singapore 1.656
Ashburn 1.617
Hong Kong 1.358
Woodbridge 1.168
Houston 1.132
Cambridge 1.035
Seattle 993
Chandler 851
Wilmington 797
Jacksonville 611
Boardman 515
Princeton 502
Ann Arbor 475
Bytom 474
Helsinki 411
Medford 371
San Diego 356
Beijing 326
Roxbury 310
Des Moines 291
Ho Chi Minh City 252
Los Angeles 206
Santa Clara 191
Padova 178
Dong Ket 154
São Paulo 153
Chicago 146
Hanoi 140
Nanjing 114
Dublin 112
New York 112
Abidjan 108
San Jose 99
Munich 94
Cotonou 92
Jinan 90
Dakar 88
Kampala 85
Tashkent 85
Amman 83
Buffalo 82
Baku 81
Panama City 81
Guangzhou 80
Milan 79
Castries 78
Bishkek 76
Vienna 76
Conakry 75
Maputo 74
Managua 73
Nairobi 73
Lima 72
Reykjavik 72
Luanda 71
Rio de Janeiro 71
Libreville 70
Montevideo 70
Accra 68
Warsaw 68
Nuremberg 66
Lusaka 65
Bridgetown 64
Antananarivo 62
Harare 62
Riga 62
Gaborone 61
Bamako 60
Havana 60
Vientiane 60
Nassau 59
Niamey 59
Phnom Penh 59
Addis Ababa 58
Andorra la Vella 58
Dar es Salaam 58
Kigali 58
London 58
Kingstown 57
Minsk 57
Rome 57
Ulan Bator 57
San José 56
Athens 55
Hefei 55
Lilongwe 55
Council Bluffs 54
Noumea 53
Yerevan 53
Dushanbe 52
Quito 52
San Pedro Sula 52
Tbilisi 52
Dili 51
Nouakchott 51
Shenyang 51
Belo Horizonte 50
Kinshasa 50
Praia 50
Totale 24.261
Salva come PNG Salva come JPEG
Nome #
Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic 266
Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options 253
2015 ESC Guidelines for the diagnosis and management of pericardial diseases 237
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. 223
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease 217
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. 214
Abnormal total ejection isovolume index as early noninvasive marker of chronic rejection in heart transplantation 210
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 210
Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? 209
Clinical presentation and diagnosis of myocarditis 200
Continuous engraftment and differentiation of male recipient Y-chromosome-positive cardiomyocytes in donor female human heart transplants 195
Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. 191
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries 189
High rejection score in the first year and risk of skin cancer in heart transplantation 188
Cardiac Magnetic Resonance Features of Biopsy-Proven Endomyocardial Diseases. 188
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 186
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis 184
The multiple faces of autoimmune/immune‐mediated myocarditis in children: a biopsy‐proven case series treated with immunosuppressive therapy 184
Clinical Value and Time Course of Pericoronary Fat Inflammation in Patients with Angiographically Nonobstructive Coronaries: A Preliminary Report 184
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 183
Myocarditis mimicking Takotsubocardiomyopathy or Takotsubo cardiomyopathy with secondary inflammation?: reply. 179
Association Between Common Cardiovascular Risk Factors and Clinical Phenotype in Patients with Hypertrophic Cardiomyopathy From the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis Registry 179
Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosuppressive load 177
Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. 175
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 175
A novel circulating noncoding small RNA for the detection of acute myocarditis 173
Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family History 170
Coronary Flow Reserve by Transthoracic Echocardiography Predicts Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 169
Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: a propensity weighted study. 168
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 168
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? 166
Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation 165
De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis 163
High rejection score in the first year and risk of skin cancer in heart transplantation 163
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 162
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 162
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 161
Myocarditis: A Clinical Overview 161
THU0532 RITUXIMAB FOR RAPIDLY PROGRESSIVE JUVENILE SYSTEMIC SCLEROSIS 160
Efficacy of immunosuppressive therapy in myocarditis: A 30-year systematic review and meta analysis 159
Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft 157
Autoimmune myocarditis and dilated cardiomyopathy: Focus on cardiac autoantibodies 156
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy 156
Clinically suspected myocarditis with pseudo-infarct presentation: The role of endomyocardial biopsy 155
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 155
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? 154
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee 153
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. 153
Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection 150
Sulfinpyrazone reduces cyclosporine levels: a new drug interaction in heart transplant recipients 150
How to improve therapy in myocarditis: role of cardiovascular magnetic resonance and of endomyocardial biopsy 150
Skin disorders in patients transplanted in childhood 150
Strain and strain rate by velocity vector imaging in diagnosing acute rejection after heart transplantation 149
CMR Predictors of Favorable Outcome in Myocarditis: A Single-Center Experience 148
Skin cancer in heart transplant recipients: Frequency and risk factor analysis 148
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias 147
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) 147
Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. 146
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. 145
Monoclonal gammopathy in heart transplantation: Risk factor analysis and relevance of immunosuppressive load 145
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 144
Occurrence of post-transplant lymphoproliferative disorders among over thousandadult recipients: any role for hepatitis C infection? 142
Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy 140
Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. 140
Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review 140
Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies. 139
Abnormal cellularity in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy 138
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis 138
Recurrent pericarditis: Autoimmune or autoinflammatory? 136
Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term 136
Prospective follow-up in various subtypes of cardiomyopathies: Insights from the ESC EORP Cardiomyopathy Registry 136
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology 136
A rare cause of effusive–constrictive pericarditis 136
Assessment of coronary inflammation by pericoronary fat attenuation index in clinically suspected myocarditis with infarct-like presentation 136
Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis 136
Microvasculopathy Preceeds Epicardial Coronary Stenosis in Heart Transplant Patients with Cardiac Allograft Vasculopathy 134
Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis 134
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions 134
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry 134
Genetically determined myocarditis: clinical presentation and immunological characteristics 133
Skin cancer in heart transplant recipients: frequency and risk factor analysis 133
High rejection score in the first year and risk of skin cancer in heart transplantation 133
Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection 133
Anti-heart autoantibodies in familial dilated cardiomyopathy 132
Endothelial Progenitor Cells Are Decreased in the Blood and in the Graft of Heart Transplant Patients with Microvasculopathy 132
Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation 132
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients 130
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity 130
Triage strategy for urgent management of cardiac tamponade: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 129
Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy 129
Potential role of circulating progenitor cells in coronary microvascular dysfunction of heart transplant patients with normal coronary angiograms 128
Microvascular dysfunction in left apical ballooning syndrome: Primary cause or secondary phenomenon? 128
De novo noncutaneous malignancies in heart transplantation: A single-centre 15-year experience and risk factor analysis 127
[ANMCO/SIC Consensus document on the management of myocarditis] 127
Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis 127
Cardiac Magnetic Resonance Imaging in Biopsy-proven Myocarditis: Lack of Relationship With Clinical Presentation and Viral Etiology 126
Immunosuppressive treatment in familial dilated cardiomyopathy with biopsy-proven intramyocardial inflammation? 125
Endothelial Progenitor Cells Are Decreased In the Blood And In The Graft Of Heart Transplant Patients With Microvasculopathy 125
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy 125
Monoclonal gammopathy in heart transplantation: clinical significance and risk factors 122
Totale 15.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.826
article - articoli 122.001
book - libri 291
conference - conferenze 0
curatela - curatele 0
other - altro 500
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.326
Totale 256.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.666 0 0 0 0 0 0 165 272 429 215 322 263
2021/20224.872 95 598 701 378 155 239 167 613 246 66 349 1.265
2022/20232.324 836 174 24 209 305 255 5 118 243 35 100 20
2023/20241.260 67 116 121 111 67 63 85 49 40 85 194 262
2024/20257.063 48 299 276 136 779 109 372 527 778 402 1.371 1.966
2025/202618.353 851 2.955 4.688 5.726 2.502 1.302 329 0 0 0 0 0
Totale 42.683